MedPath

Evaluation of the effect of gabapentin in reducing pai

Phase 3
Recruiting
Conditions
Reduction of pain after laparoscopic endometriosis surgery.
Registration Number
IRCT20150817023666N14
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
140
Inclusion Criteria

Endometriosis patients aged 16-40 years in Stage 3 and 4 diseases

Exclusion Criteria

Kidney and liver patients
patients with gabapentin allergy
patients with mental disorders and epilepsy
patients who have taken painkillers and any drugs and cigarettes one week before surgery

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction of pain and drug use after laparoscopic surgery. Timepoint: 6, 12 and 24 hours after surgery. Method of measurement: Pain questionnaire based on Visual Analogue Scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath